By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TiGenix 

Head Office
Technologielaan 3
Leuven    B - 3001  Belgium
Phone: 32-16-39-60-60 Fax: 32-16-39-60-70


SEARCH JOBS


Industry
Biotechnology






Company News
TiGenix To Present At The 7th TERMIS-EU Conference In Davos, Switzerland 6/23/2017 9:09:53 AM
Takeda (TKPYY) And TiGenix Announce That Swissmedic Has Accepted For Review The File On Cx601 For The Treatment Of Complex Perianal Fistulas In Crohn's Disease Patients 6/20/2017 9:30:35 AM
TiGenix Partners With U.S. And European Patient Advocacy Groups Focused On Crohn’s Disease And Ulcerative Colitis 6/15/2017 10:55:37 AM
TiGenix Launches Global Phase III Trial For Cx601 6/13/2017 1:11:46 PM
TiGenix Announces Final Equity Payment For Cardiac Platform Acquisition 6/12/2017 1:56:29 PM
TiGenix Announces Final Equity Payment For Cardiac Platform Acquisition 6/12/2017 11:43:16 AM
TiGenix To Present At The Jefferies 2017 Global Healthcare Conference In New York 6/1/2017 1:39:24 PM
TiGenix Provides Regulatory Update On Cx601 EU Marketing Authorization Application Procedure 5/31/2017 10:58:03 AM
TiGenix To Participate At International Scientific And Industry Conferences 5/17/2017 12:41:11 PM
TiGenix To Present At Bank of America (BAC) Merrill Lynch 2017 Healthcare Conference In Las Vegas 5/12/2017 12:10:14 PM
12345678910...
//-->